why is my glp 1 injection site itchy Rash from a GLP-1 explained by an allergist 👆, Thanks to friend @rubin_allergy for the information in this video GLP-1 Injection Site Reactions: What

GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring FGF7

Current guidelines from the American Diabetes Association now favor GLP-1 agonists over insulin as the first injectable therapy for most patients with Type 2 diabetes

These are generally most pronounced during the dose titration phase and tend to diminish as the body adjusts to treatment

4 Related Stories Exercise, not liraglutide alone, drives vascular gains after obesity-related weight loss Weight loss medications show promise in preventing obesity-related cancers GLP-1 drugs may reduce lung scarring from Long COVID in diabetic patients Mechanistically, binding to GLP-1R activates adenylate cyclase (AC), subsequently increasing cAMP to trigger both protein kinase A (PKA) and exchange protein directly activated by cAMP 2 (Epac2)

For GLP-1 medications, this translates to: Semaglutide Steady state reached after approximately 45 weeks of weekly injections Dulaglutide Steady state reached after approximately 24 weeks Liraglutide Steady state reached after approximately 3 days of daily injections Exenatide extended-release Steady state reached after approximately 67 weeks Short-acting agents (exenatide immediate-release, lixisenatide) Steady state reached within 12 days Once steady state is achieved, the medication concentration remains relatively constant, fluctuating only slightly between doses